122 related articles for article (PubMed ID: 36733163)
1. [A Case of Locally Advanced Breast Cancer That Responded to Paclitaxel plus Bevacizumab and Underwent Radical Surgery].
Oshima K; Mitsuyoshi A; Kikumori K; Hori A; Yanagawa T; Shinke G; Katsuyama S; Ikeshima R; Hiraki M; Ohmura Y; Sugimura K; Masuzawa T; Hata T; Takeda Y; Murata K
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1645-1647. PubMed ID: 36733163
[TBL] [Abstract][Full Text] [Related]
2. Locally advanced breast cancer with bleeding - two cases effectively treated with bevacizumab plus weekly paclitaxel.
Ishizuna K; Ninomiya J; Ogawa T; Kojima M; Kawashima M; Nozaki M; Yamagishi H; Ueda Y
Gan To Kagaku Ryoho; 2014 May; 41(5):637-40. PubMed ID: 24917012
[TBL] [Abstract][Full Text] [Related]
3. [Paclitaxel plus Bevacizumab Therapy plus Surgical Resection Results in Local Control of Stage ⅢC Breast Cancer].
Tanaka M; Ono S; Nohara Y; Yoshinaga Y; Sato T; Yamashita S; Morita A; Takagi S
Gan To Kagaku Ryoho; 2021 Nov; 48(11):1393-1395. PubMed ID: 34795133
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel-resistant advanced recurrent breast cancer: a case of partial response due to addition of bevacizumab to paclitaxel therapy: a case report.
Ishizuna K; Ninomiya J; Kojima M; Kawashima M; Nozaki M; Yamagishi H; Ueda Y; Oya M
BMC Res Notes; 2013 Jul; 6():254. PubMed ID: 23830415
[TBL] [Abstract][Full Text] [Related]
5. [A case of effective trastuzumab plus gemcitabine therapy for human epidermal growth factor receptor 2-positive breast cancer].
Yabe N; Murai S; Shimizu H; Kitasato K; Yoshikawa T; Oto I; Nakadai J; Jinno H; Kitagawa Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2396-8. PubMed ID: 24394124
[TBL] [Abstract][Full Text] [Related]
6. [Case Report of Long-Term Clinical Efficacy of Paclitaxel plus Bevacizumab Combination Therapy for Stage Ⅳ AdvancedBreast Cancer].
Sugimoto H; Miura T; Kawamura Y; Aburatani T; Hanaoka M; Ogo T; Hoshino N; Nishioka Y; Kawano T
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2246-2248. PubMed ID: 32156893
[TBL] [Abstract][Full Text] [Related]
7. [Combination Therapy of Bevacizumab plus Paclitaxel Was Effective for a Metastatic Choroidal Tumor Secondary to Breast Cancer in a Patient with Ocular Symptoms].
Hattori M; Shirahane K; Sakai M; Sassa Y; Nishihara Y; Aibe H; Masuda M; Mori D
Gan To Kagaku Ryoho; 2020 Aug; 47(8):1221-1224. PubMed ID: 32829359
[TBL] [Abstract][Full Text] [Related]
8. [A Case of Locally Advanced and Metastatic Breast Cancer Treated with Preoperative Bevacizumab Combination Chemotherapy That Attained Local Control].
Watanabe N; Furukawa J; Minoji T; Tamai K; Kitahara T; Yamamura N; Okamura S; Fukuchi N; Ebisui C; Yokouchi H; Kinuta M
Gan To Kagaku Ryoho; 2018 Jul; 45(7):1097-1099. PubMed ID: 30042280
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Advanced Breast Cancer Effectively Treated with Bevacizumab and Letrozole].
Hara Y; Sakurai K; Adachi K; Fujiwara A; Ono Y; Waga E; Hirano T; Enomoto K
Gan To Kagaku Ryoho; 2018 Feb; 45(2):368-370. PubMed ID: 29483450
[TBL] [Abstract][Full Text] [Related]
10. [Clinical Efficacy of Paclitaxel plus Bevacizumab Combination Therapy for Bone Marrow Carcinomatosis Arising from Breast Cancer - A Case Report].
Nakayama I
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1391-1392. PubMed ID: 29394644
[TBL] [Abstract][Full Text] [Related]
11. [A complete response following treatment with Paclitaxel and bevacizumab for metastatic breast cancer].
Tsubota Y; Sueoka N; Yamamoto D
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1954-6. PubMed ID: 25731387
[TBL] [Abstract][Full Text] [Related]
12. Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial.
Saji S; Taira N; Kitada M; Takano T; Takada M; Ohtake T; Toyama T; Kikawa Y; Hasegawa Y; Fujisawa T; Kashiwaba M; Ishida T; Nakamura R; Yamamoto Y; Toh U; Iwata H; Masuda N; Morita S; Ohno S; Toi M
Lancet Oncol; 2022 May; 23(5):636-649. PubMed ID: 35405087
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of neoadjuvant weekly nab-paclitaxel and carboplatin, with bevacizumab and trastuzumab, as treatment for women with locally advanced HER2+ breast cancer.
Yardley DA; Raefsky E; Castillo R; Lahiry A; Locicero R; Thompson D; Shastry M; Burris HA; Hainsworth JD
Clin Breast Cancer; 2011 Oct; 11(5):297-305. PubMed ID: 21729666
[TBL] [Abstract][Full Text] [Related]
14. [A case of triple-negative breast cancer responding to multidisciplinary treatment containing bevacizumab].
Noma M; Ohara M; Imaoka Y; Mashima H; Mizota S; Okimoto S; Takakura Y; Oishi K; Kohashi T; Ikeda S; Fudaba Y; Matsugu Y; Ishimoto T; Nakahara H; Urushihara T; Itamoto T; Doi M; Nishisaka T
Gan To Kagaku Ryoho; 2014 Apr; 41(4):483-6. PubMed ID: 24743365
[TBL] [Abstract][Full Text] [Related]
15. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
[TBL] [Abstract][Full Text] [Related]
16. [A Case of Drug-Induced Lung Injury Associated with Paclitaxel plus Bevacizumab Therapy].
Yamaguchi Y; Tada Y; Takaya S; Iwamoto A; Yamashiro Y; Shibata S; Ishiguro M; Nishidoi H
Gan To Kagaku Ryoho; 2016 Jun; 43(6):781-4. PubMed ID: 27306821
[TBL] [Abstract][Full Text] [Related]
17. SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer.
Nahleh ZA; Barlow WE; Hayes DF; Schott AF; Gralow JR; Sikov WM; Perez EA; Chennuru S; Mirshahidi HR; Corso SW; Lew DL; Pusztai L; Livingston RB; Hortobagyi GN
Breast Cancer Res Treat; 2016 Aug; 158(3):485-95. PubMed ID: 27393622
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of bevacizumab with paclitaxel for advanced breast cancer - a case report].
Morishita A; Mitsuhashi S; Fujisawa F; Hirano M; Kojima H
Gan To Kagaku Ryoho; 2013 Jun; 40(6):761-4. PubMed ID: 23863653
[TBL] [Abstract][Full Text] [Related]
19. [A Case of Recurrent Breast Cancer with Carcinomatous Pleurisy Successfully Treated with Paclitaxel and Bevacizumab after Radical Mastectomy].
Sakaguchi N; Moriya T; Yamazaki T; Yamagishi Y; Hasegawa S; Tsuda H; Hase K; Yamamoto J
Gan To Kagaku Ryoho; 2015 Jun; 42(6):751-3. PubMed ID: 26199251
[TBL] [Abstract][Full Text] [Related]
20. [Preoperative therapy using trastuzumab and weekly paclitaxel in a stage IIIB inoperable locally advanced HER2- positive breast cancer with complete pathologic response].
Rai Y; Sagara Y; Ooi Y; Sagara Y; Sagara Y; Baba S; Tamada S; Matsuyama Y; Ando M
Gan To Kagaku Ryoho; 2009 Mar; 36(3):471-3. PubMed ID: 19295274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
